Zum Inhalt springen

NOF to Sponsor Vaccines & Immunotherapies Online Symposium 2024

NOF to Sponsor Vaccines & Immunotherapies Online Symposium 2024

Vaccines & Immunotherapies Online Symposium ( September 26, 2024)

NOF EUROPE GmbH 8/05/2024

NOF CORPORATION is pleased to announce its sponsor and participation in the upcoming Vaccines & Immunotherapies Online Symposium on 26th September 2024.

Symposium Website: https://oxfordglobal.com/biolo... 

In the symposium, NOF CORPORATION will showcase its latest technologies and products for Drug Delivery System, which include: 

  • SS-cleavable and pH-responsive lipids for nucleic acids/gene delivery and vaccines 
  • Novel lipids and cationic lipids for LNP formulation In addition, a presentation (recorded) by a NOF CORPORATION scientist will be given at 15:20 BST

【Title】 

Biodegradable Lipid Nanoparticles for Gene Therapy and Vaccines 

【Time】 

15:20 BST 

【Bullet points of presentation】 

  • Overview of our biodegradable ionizable lipids (COATSOME®SS-OP and COATSOME®SS-EC) 
  • Highlighting safety profile and gene therapy/vaccine applications of our proprietary ionizable lipids 
  • A lyophilized LNP with room temperature stability that overcomes the cold-chain handling limitations.


If you are interested in our technology, please contact our regional offices below to learn more and to arrange a meeting.

Americas
NOF AMERICA CORPORATION
E-mail: info@nofamerica.com
Tel: 

New York Office: +1-914-681-9790
San Francisco Office: +1-650-993-7375
Boston Office: +1-914-704-7903

Europe
NOF EUROPE GmbH
E-mail: info-eu@nofeurope.com
Tel: +49 (0)69 7706 100 0

Asia Pacific, Japan
NOF CORPORATION
Life Science Division
E-mail: ddsinfo@nof.co.jp
Tel: +81-3-5424-6741

China
NOF (Shanghai) Co. Ltd.

Tel: +86-21-6210-1100